one8zero8 LLC’s Lifecore Biomedical LFCR Stock Holding History

one8zero8 LLC’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,000	Closed	-$37.2K	–	269
2026 Q1	$37.2K	Buy	+10,000	New	+$69K	0.01%	237

Other funds holding LFCR

Wynnefield Capital New York $145M AUM 14.57% 1-Year Est. Return

LPAM

Legion Partners Asset Management Los Angeles, California $40.6M AUM 156.55% 1-Year Est. Return

GRIM

Greenhaven Road Investment Management Greenwich, Connecticut $154M AUM 15.9% 1-Year Est. Return

325 Capital New York $419M AUM 75.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

QOP

Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return

one8zero8 LLC's LFCR Position: Q2 2026 in Review

one8zero8 LLC sold out of Lifecore Biomedical (LFCR) in Q2 2026, closing a stake of 10,000 shares — an estimated $37.2K sold.

one8zero8 LLC first reported a position in LFCR in Q1 2026 and held it in 1 quarter. The position peaked at $37.2K in Q1 2026. 99 funds tracked by Wall St. Rank hold LFCR as of Q2 2026.

one8zero8 LLC reported no remaining Lifecore Biomedical position as of Q2 2026 after selling out during the quarter.
one8zero8 LLC sold 10,000 Lifecore Biomedical shares in Q2 2026, an estimated $37.2K.
one8zero8 LLC first reported a position in Lifecore Biomedical in Q1 2026 and held it in 1 quarter.
one8zero8 LLC's Lifecore Biomedical position peaked at $37.2K in Q1 2026.
99 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2026.

Based on one8zero8 LLC's 13F filing for Q2 2026, filed 10 Aug 2026.